Aptus Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.7M	Sell	46,240 -11,704	-20%	-$6.35M	0.19%	107
2025 Q4	$33.6M	Buy	57,944 +1,757	+3%	+$994K	0.29%	82
2025 Q3	$27.3M	Buy	56,187 +44,485	+380%	+$20.7M	0.25%	104
2025 Q2	$4.74M	Buy	11,702 +3,031	+35%	+$1.27M	0.05%	304
2025 Q1	$4.31M	Sell	8,671 -34,309	-80%	-$18.6M	0.05%	300
2024 Q4	$22.4M	Buy	42,980 +5,215	+14%	+$2.87M	0.27%	94
2024 Q3	$23.4M	Buy	37,765 +5,996	+19%	+$3.55M	0.35%	71
2024 Q2	$17.6M	Buy	31,769 +6,695	+27%	+$3.84M	0.33%	75
2024 Q1	$14.6M	Buy	25,074 +2,607	+12%	+$1.46M	0.31%	80
2023 Q4	$11.9M	Buy	22,467 +34	+0.2%	+$16.5K	0.35%	74
2023 Q3	$11.4M	Sell	22,433 -988	-4%	-$526K	0.33%	76
2023 Q2	$12.2M	Sell	23,421 -1,234	-5%	-$666K	0.36%	76
2023 Q1	$14.2M	Buy	24,655 +1,709	+7%	+$963K	0.41%	53
2022 Q4	$12.6M	Sell	22,946 -1,587	-6%	-$841K	0.42%	53
2022 Q3	$12.4M	Buy	24,533 +1,624	+7%	+$909K	0.4%	49
2022 Q2	$12.4M	Sell	22,909 -16	-0.1%	-$8.81K	0.41%	44
2022 Q1	$13.5M	Buy	22,925 +3,033	+15%	+$1.74M	0.42%	36
2021 Q4	$13.3M	Buy	19,892 +3,009	+18%	+$1.88M	0.45%	34
2021 Q3	$9.65M	Buy	16,883 +4,049	+32%	+$2.22M	0.38%	51
2021 Q2	$6.47M	Buy	12,834 +6,117	+91%	+$2.89M	0.29%	64
2021 Q1	$3.06M	Buy	6,717 +155	+2%	+$74K	0.16%	99
2020 Q4	$3.06M	Buy	6,562 +948	+17%	+$444K	0.18%	95
2020 Q3	$2.48M	Buy	5,614 +48	+0.9%	+$19.8K	0.18%	102
2020 Q2	$2.02M	Sell	5,566 -888	-14%	-$298K	0.17%	105
2020 Q1	$1.83M	Buy	+6,454	New	+$2.04M	0.19%	110